Bioxytran Highlights Advances in Real-Time Tissue Oxygenation Mapping Relevant to Investigational Oxygen Therapeutic BXT-25
BOSTON, MASSACHUSETTS, May 29, 2026 — Bioxytran Inc. (OTCQB: BIXT), a biotechnology company developing carbohydrate-based therapeutics and oxygen transport technologies, today highlighted the publication of a newly released scientific book that may provide valuable insights into future evaluation methods for investigational oxygen therapeutics such as BXT-25.
June 22, 2026